Use of transvenous DDD pacing in a one-year-old with symptomatic hypertrophic cardiomyopathy

Pediatr Cardiol. 1998 May-Jun;19(3):253-5. doi: 10.1007/s002469900298.

Abstract

Symptomatic hypertrophic cardiomyopathy (HCM) is rare in infants. Therapeutic options are limited and include beta-blocker or calcium-channel blocker therapy or surgical myotomy/myectomy. Atrioventricular sequential pacing has been utilized as an alternative to surgery in symptomatic adults with HCM. We report our results with transvenous dual chamber pacing in an infant with symptomatic HCM.

Publication types

  • Case Reports

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use
  • Cardiac Pacing, Artificial / methods*
  • Cardiomyopathy, Hypertrophic / diagnostic imaging
  • Cardiomyopathy, Hypertrophic / therapy*
  • Echocardiography
  • Hemodynamics / drug effects
  • Humans
  • Infant, Newborn
  • Male
  • Propranolol / therapeutic use

Substances

  • Anti-Arrhythmia Agents
  • Propranolol